Frontiers in Pharmacology (Jun 2023)

Mitochondrial homeostasis: a potential target for delaying renal aging

  • Ming Yang,
  • Ming Yang,
  • Chongbin Liu,
  • Chongbin Liu,
  • Na Jiang,
  • Na Jiang,
  • Yan Liu,
  • Yan Liu,
  • Shilu Luo,
  • Shilu Luo,
  • Chenrui Li,
  • Chenrui Li,
  • Hao Zhao,
  • Hao Zhao,
  • Yachun Han,
  • Yachun Han,
  • Wei Chen,
  • Wei Chen,
  • Li Li,
  • Li Li,
  • Li Xiao,
  • Li Xiao,
  • Lin Sun,
  • Lin Sun

DOI
https://doi.org/10.3389/fphar.2023.1191517
Journal volume & issue
Vol. 14

Abstract

Read online

Mitochondria, which are the energy factories of the cell, participate in many life activities, and the kidney is a high metabolic organ that contains abundant mitochondria. Renal aging is a degenerative process associated with the accumulation of harmful processes. Increasing attention has been given to the role of abnormal mitochondrial homeostasis in renal aging. However, the role of mitochondrial homeostasis in renal aging has not been reviewed in detail. Here, we summarize the current biochemical markers associated with aging and review the changes in renal structure and function during aging. Moreover, we also review in detail the role of mitochondrial homeostasis abnormalities, including mitochondrial function, mitophagy and mitochondria-mediated oxidative stress and inflammation, in renal aging. Finally, we describe some of the current antiaging compounds that target mitochondria and note that maintaining mitochondrial homeostasis is a potential strategy against renal aging.

Keywords